Search Results - "Morton, Gerard C."

Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial by Michalski, Jeff M., MD, Yan, Yan, MD, MS, Watkins-Bruner, Deborah, PhD, Bosch, Walter R., DSc, Winter, Kathryn, MS, Galvin, James M., DSc, Bahary, Jean-Paul, MD, Morton, Gerard C., MB, Parliament, Matthew B., MD, Sandler, Howard M., MD

“…Purpose To give a preliminary report of clinical and treatment factors associated with toxicity in men receiving high-dose radiation therapy (RT) on a phase 3…”
Get full text

The evolution of brachytherapy for prostate cancer by Zaorsky, Nicholas G., Davis, Brian J., Nguyen, Paul L., Showalter, Timothy N., Hoskin, Peter J., Yoshioka, Yasuo, Morton, Gerard C., Horwitz, Eric M.

“…Key Points Brachytherapy and brachytherapy boost with low-dose-rate brachytherapy (LDR-BT) or high-dose-rate (HDR)-BT can be used as first-line therapies in…”
Get full text

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique by Morton, Gerard C

“…High-dose-rate brachytherapy (HDR) is a method of conformal dose escalation to the prostate. It can be used as a local boost in combination with external beam…”
Get full text

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial by Movsas, Benjamin, Rodgers, Joseph P, Elshaikh, Mohamed A, Martinez, Alvaro A, Morton, Gerard C, Krauss, Daniel J, Yan, Di, Citrin, Deborah E, Hershatter, Bruce W, Michalski, Jeff M, Ellis, Rodney J, Kavadi, Vivek S, Gore, Elizabeth M, Gustafson, Gary S, Schulz, Craig A, Velker, Vikram M, Olson, Adam C, Cury, Fabio L, Papagikos, Michael A, Karrison, Theodore G, Sandler, Howard M, Bruner, Deborah W

“…To report patient-reported outcomes (PROs) of a phase III trial evaluating total androgen suppression (TAS) combined with dose-escalated radiation therapy (RT)…”
Get full text

Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Men With Intermediate-Risk Prostate Cancer: Analysis of Short- and Medium-Term Toxicity and Quality of Life by Morton, Gerard C., M.B., F.R.C.P.C, Loblaw, D. Andrew, M.D., M.Sc., F.R.C.P.C, Sankreacha, Raxa, M.Sc, Deabreu, Andrea, Zhang, Liying, Ph.D, Mamedov, Alexandre, Cheung, Patrick, M.D., F.R.C.P.C, Keller, Brian, Ph.D, Danjoux, Cyril, M.D., F.R.C.P.C, Szumacher, Ewa, M.D., M.Ed., F.R.C.P.C, Thomas, Gillian, B.Sc., M.D., F.R.C.P.C

“…Purpose To determine the short- and medium-term effects of a single high-dose-rate brachytherapy fraction of 15Gy and hypofractionated external beam radiation…”
Get full text

Health-Related Quality of Life After Single-Fraction High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy for Prostate Cancer by Morton, Gerard C., M.B., F.R.C.P.C, Loblaw, D. Andrew, M.D., M.Sc., F.R.C.P.C, Chung, Hans, M.D., F.R.C.P.C, Tsang, Gail, M.D., F.R.A.N.Z.C.R, Sankreacha, Raxa, M.Sc, Deabreu, Andrea, Zhang, Liying, Ph.D, Mamedov, Alexandre, Cheung, Patrick, M.D., F.R.C.P.C, Batchelar, Deidre, Ph.D, Danjoux, Cyril, M.D., F.R.C.P.C, Szumacher, Ewa, M.D., M.Ed., F.R.C.P.C

“…Purpose To investigate the change in health-related quality of life for men after high-dose-rate brachytherapy and external beam radiotherapy for prostate…”
Get full text

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer by Jain, Suneil, Loblaw, D. Andrew, Morton, Gerard C, Danjoux, Cyril, Szumacher, Ewa, Chu, William, Chung, Hans T, Vesprini, Danny, Sahgal, Arjun, Zhang, Liying, Deabreu, Andrea, Cheung, Patrick C.F

“…Abstract Purpose The goal of this project was to see if using IMRT to deliver elective pelvic nodal irradiation (EPNI) for prostate cancer reduced acute…”
Get full text

High dose-rate brachytherapy in the treatment of prostate cancer by Mendez, Lucas C, Morton, Gerard C

“…High dose-rate (HDR) brachytherapy involves delivery of a high dose of radiation to the cancer with great sparing of surrounding organs at risk. Prostate…”
Get full text

Single Fraction High-Dose-Rate Brachytherapy: Too Good to Be True? by Morton, Gerard C., Hoskin, Peter J.

Get full text

Prostate high-dose-rate brachytherapy: Transrectal ultrasound based planning, a technical note by Morton, Gerard C.

Get full text

Wide variation of prostate‐specific antigen doubling time of untreated, clinically localized, low‐to‐intermediate grade, prostate carcinoma by Choo, Richard, Klotz, Laurence, Deboer, Gerrit, Danjoux, Cyril, Morton, Gerard C.

“…OBJECTIVE To assess the prostate specific antigen (PSA) doubling time of untreated, clinically localized, low‐to‐intermediate grade prostate carcinoma…”
Get full text

Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer by Batchelar, Deidre L, Chung, Hans T, Loblaw, Andrew, Law, Niki, Cisecki, Thomas, Morton, Gerard C

“…Abstract Purpose Ultrasound (US)–based planning for high-dose-rate brachytherapy allows prostate patients to be implanted, imaged, planned, and treated without…”
Get full text

Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy by Holly, Rick, Morton, Gerard C, Sankreacha, Raxa, Law, Niki, Cisecki, Thomas, Loblaw, D. Andrew, Chung, Hans T

“…Abstract Purpose To determine the magnitude of catheter displacement between time of planning and time of treatment delivery for patients undergoing high…”
Get full text

Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada by Morgan, Scott C, Morton, Gerard C, Berlin, Alejandro, Cheung, Patrick, Chung, Peter, Menard, Cynthia, Pickles, Tom, Souhami, Luis, Warde, Padraig R, Lukka, Himanshu R

“…Introduction: The biennial meeting of the Genitourinary Radiation Oncologists of Canada (GUROC) took place 22-23 November 2019. A consensus-building session…”
Get full text

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression by Choo, Richard, Klotz, Laurence, Danjoux, Cyril, Morton, Gerard C, DeBoer, Gerrit, Szumacher, Ewa, Fleshner, Neil, Bunting, Peter, Hruby, George

“…We assessed the feasibility of a watchful waiting protocol with selective delayed intervention using clinical, prostate specific antigen (PSA) or histological…”
Get more information

A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy by Morton, Gerard C, Sankreacha, Raxa, Halina, Patrick, Loblaw, Andrew

“…Abstract Background and purpose Dose distribution in a high-dose-rate (HDR) brachytherapy implant is optimized by adjusting source dwell positions and dwell…”
Get full text

Low-dose metronomic daily cyclophosphamide and weekly tirapazamine : A well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia by EMMENEGGER, Urban, MORTON, Gerard C, FRANCIA, Giulio, SHAKED, Yuval, FRANCO, Marcela, WEINERMAN, Adina, SHAN MAN, KERBEL, Robert S

“…The recent clinical successes of antiangiogenic drug-based therapies have also served to highlight the problem of acquired resistance because, similar to other…”
Get full text

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients: comparative effectiveness by Yoon, Frederick, Morton, Gerard C

“…External beam radiotherapy (EBRT) is an effective treatment for symptomatic bone metastases from a variety of primary malignancies. Previous meta-analyses and…”
Get full text

An Analysis of Inter-Observer Variability in Catheter Reconstruction and Dosimetric Implications in Ultrasound-Based High-Dose-Rate Brachytherapy for Prostate Cancer by Murgic, Jure, MD, Chung, Hans T., MD, FRCPC, D’Alimonte, Laura, BSc, MRT(T), MHSc, Lu, Lin, BSc, MRT(T), Cumal, Aaron, BSc, MRT(T), Law, Niki, BSc, MRT(T), Morton, Gerard C., MD, FRCPC, Loblaw, Andrew, MD, MSc, FRCPC, Ravi, Ananth, PhD, MCCPM

Get full text

PSA doubling time of prostate carcinoma managed with watchful observation alone by Choo, R, DeBoer, G, Klotz, L, Danjoux, C, Morton, G C, Rakovitch, E, Fleshner, N, Bunting, P, Kapusta, L, Hruby, G

“…To study prostate-specific antigen (PSA) doubling time of untreated, favorable grade, prostate carcinoma. A prospective single-arm cohort study has been in…”
Get more information